To follow up on last week’s blog (here). I came across the Amicus Curiae brief filed by the Solicitor General in the Teva v Glaxo case regarding the skinny label provisions of the Hatch-Waxman Act.  I thought you would be interested in reading the brief for this important case so here it is!  Enjoy the read.